Ty Brown, MD
Clinical Neurophysiology · Crestview Hills, KYNPI 1205037470
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 320 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,525 and has fallen 55.1% since, to $684 in 2025.
Across 320 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amneal Pharmaceuticals LLC$1K
- SK Life Science, Inc.$825
- Ceribell, Inc.$703
- AbbVie$591
- Acadia Pharmaceuticals Inc$362
- Jazz Pharmaceuticals Inc.$348
- plus $2K from 34 others
What the payments were for
- Speaking & faculty fees$210%
- Food & beverage$6,50199%
- Education$651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amneal Pharmaceuticals LLC | 80 | $1,272 |
| SK Life Science, Inc. | 15 | $825 |
| Ceribell, Inc. | 5 | $703 |
| AbbVie(2 entities) | 28 | $591 |
| Acadia Pharmaceuticals Inc | 13 | $362 |
| Jazz Pharmaceuticals Inc. | 15 | $348 |
| Supernus Pharmaceuticals, Inc. | 71 | $330 |
| Sanofi | 3 | $255 |
| Biogen | 7 | $245 |
| Sunovion Pharmaceuticals Inc. | 15 | $186 |
| UCB, Inc. | 7 | $144 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $135 |
| Lilly USA, LLC | 7 | $112 |
| Novartis | 5 | $106 |
| Eisai Inc. | 5 | $103 |
| Amgen | 5 | $97 |
| Idorsia Pharmaceuticals US Inc | 1 | $89 |
| Teva Pharmaceuticals USA, Inc. | 3 | $70 |
| EMD Serono, Inc. | 3 | $57 |
| Banner Life Sciences, LLC | 2 | $54 |
| TG Therapeutics, Inc. | 2 | $46 |
| Upsher-smith Laboratories LLC | 2 | $45 |
| Genentech USA, Inc. | 3 | $44 |
| Johnson & Johnson | 1 | $36 |
| Greenwich Biosciences, Inc. | 2 | $34 |
| AstraZeneca | 2 | $32 |
| Pfizer | 2 | $28 |
| Kyowa Kirin, Inc. | 1 | $24 |
| CSL Behring | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Acorda Therapeutics, Inc | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| GE HealthCare | 1 | $21 |
| Neurelis, Inc. | 1 | $19 |
| Avion Pharmaceuticals | 1 | $19 |
| Abbott | 1 | $16 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
| Livanova USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XCOPRI$356
- POCKET EEG DEVICE$339
- Ceribell Rapid Response EEG$311
- NUPLAZID$269
- QULIPTA$245
- RYTARY$230
- NURTEC ODT$125
- CREXONT$124
- AUBAGIO$121
- UBRELVY$120
- DISEASE STATE$117
- Epidiolex$107
- APTIOM$106
How this compares
Too few clinical neurophysiology providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TecfideraDimethyl Fumarate | 13 | $122,816 |
| Oxtellar XrOxcarbazepine | 35 | $113,676 |
| XcopriCenobamate | 99 | $101,125 |
| VumerityDiroximel Fumarate | 12 | $96,856 |
| EpidiolexCannabidiol (Cbd) | 33 | $53,318 |
| NuedextaDextromethorphan Hbr/Quinidine | 39 | $52,706 |
| FycompaPerampanel | 32 | $37,512 |
| NeurontinGabapentin | 11 | $36,771 |
| VimpatLacosamide | 11 | $24,313 |
| LamictalLamotrigine | 25 | $21,724 |
| Lacosamide | 145 | $18,120 |
| UbrelvyUbrogepant | 15 | $17,658 |
| Levetiracetam | 266 | $12,142 |
| Topiramate ErTopiramate | 22 | $11,791 |
| Dalfampridine ErDalfampridine | 16 | $7,060 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BiogenTecfidera, Vumerity | $245 | $219,67225 claims |
| Supernus Pharmaceuticals, Inc.Oxtellar Xr | $330 | $113,67635 claims |
| SK Life Science, Inc.Xcopri | $825 | $101,12599 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $12 | $52,70639 claims |
| Eisai Inc.Fycompa | $103 | $37,51232 claims |
| UCB, Inc.Vimpat | $144 | $24,31311 claims |
| AbbVieUbrelvy | $591 | $17,65815 claims |
| PfizerDilantin | $28 | $3,99224 claims |
| Upsher-smith Laboratories LLCTopiramate | $45 | $2,263141 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical neurophysiology providers in Kentuckyon file to place this against a meaningful peer group, so we don't.
Other clinical neurophysiology in Crestview Hills
- Warren ChumleyLexington$288K
- Disha ShahLouisville$122K
- Ima EbongLexington$12K
- Greg AndersonLexington$8K
- Ashar FarooqiLexington$3K
- Jordan ClayLexington$2K
- Hassan SouidanElizabethtown$2K
- James ThompsonLouisville$941
- Ping ShiLouisville$648
- Priyanka YadavLexington$588
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.